Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jan;49(1):107–108. doi: 10.1038/bjc.1984.17

Plasma dopamine-beta-hydroxylase in neuroblastoma.

M Schöni, H Käser
PMCID: PMC1976687  PMID: 6691896

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brewster M. A., Berry D. H. Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma. Med Pediatr Oncol. 1979;6(2):93–99. doi: 10.1002/mpo.2950060202. [DOI] [PubMed] [Google Scholar]
  2. Eldeeb B. B., Burns S., Robinson R., Hammond E. M., Mann J. R. Serum dopamine beta hydroxylase in children with neuroblastoma. Br J Cancer. 1983 Jan;47(1):115–121. doi: 10.1038/bjc.1983.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goldstein M., Freedman L. S., Bohuon A. C., Guerinot F. Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med. 1972 May 25;286(21):1123–1125. doi: 10.1056/NEJM197205252862102. [DOI] [PubMed] [Google Scholar]
  4. Nagatsu T., Udenfriend S. Photometric assay of dopamine- -hydroxylase activity in human blood. Clin Chem. 1972 Sep;18(9):980–983. [PubMed] [Google Scholar]
  5. Weinshilboum R. M. Serum dopamine beta-hydroxylase. Pharmacol Rev. 1978 Jun;30(2):133–166. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES